Douglas E. Williams's most recent trade in Climb Bio Inc. was a trade of 40,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Climb Bio Inc. | Douglas E. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Climb Bio Inc. | Douglas E. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 78,873 | 78,873 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Douglas E. Williams | EVP & President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 301,875 | 301,875 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Douglas E. Williams | EVP & President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 67,083 | 67,083 | - | - | Restricted Stock Units | |
| Sana Biotechnology Inc | Douglas E. Williams | EVP & President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2023 | 1,100,000 | 1,100,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Douglas E. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 1,750 | 1,750 | - | - | Stock Option (Right to Buy) |